Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

299

To be discontinued: 2 (1%)
Discontinued: 297 (99%)
Reversed: 0 (0%)

Late reports

361 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-02-17 2022-03-24 155155
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95373
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-10-10 95378
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2019-10-03 2019-11-01 95381
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-01-09 2020-02-21 102893
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2022-11-14 2023-01-12 174595
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Resolved 2020-10-22 2020-11-12 126918
DOXORUBICIN HYDROCHLORIDE INJECTION 2MG SOLUTION Actual shortage 2024-06-07 2025-03-27 229963
DULOXETINE DR 60MG CAPSULE (DELAYED RELEASE) Resolved 2018-03-16 2018-11-08 43119
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2018-12-04 2019-08-06 68608
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2019-08-22 2019-10-24 92180
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2024-12-20 2025-01-18 246254
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2021-02-05 2021-03-11 133445
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-02-17 2023-04-28 185077
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-08 2023-10-03 194144
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-06-20 2023-07-05 195784
EPIRUBICIN FOR INJECTION 2MG SOLUTION Resolved 2023-10-19 2023-11-30 207533
EPTIFIBATIDE INJECTION 0.75MG SOLUTION Resolved 2017-03-13 2020-02-13 1691
EPTIFIBATIDE INJECTION 2MG SOLUTION Resolved 2017-03-13 2020-02-13 1694
ETOPOSIDE INJECTION 20MG LIQUID Resolved 2023-06-20 2023-07-28 195789

Showing 381 to 400 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2025-03-20 2025-03-20 253165
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2024-10-11 2024-10-11 240081
TEVA-MIRTAZAPINE 30MG TABLET Discontinued 2021-02-12 2021-02-12 133908
TEVA-NAPROXEN 250MG TABLET Discontinued 2017-06-27 2017-06-27 14055
TEVA-NAPROXEN SODIUM DS 550MG TABLET Discontinued 2019-04-11 2019-04-11 81350
TEVA-NORFLOXACIN 400MG TABLET Discontinued 2018-10-19 2018-10-19 65013
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63946
TEVA-NYSTATIN 100000UNIT SUSPENSION Discontinued 2018-10-12 2018-10-12 63949
TEVA-NYSTATIN 100000UNIT CREAM Discontinued 2020-07-10 2020-07-10 120056
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-06-28 2024-06-29 231586
TEVA-OXYBUTYNIN 5MG TABLET Discontinued 2024-10-11 2024-10-11 240078
TEVA-PANTOPRAZOLE MAGNESIUM 40MG TABLET (DELAYED-RELEASE) Discontinued 2021-02-12 2021-02-12 133891
TEVA-PAROXETINE 10MG TABLET Discontinued 2025-03-20 2025-03-20 253182
TEVA-PAROXETINE 10MG TABLET Discontinued 2019-04-11 2019-04-11 81313
TEVA-PAROXETINE 20MG TABLET Discontinued 2025-03-20 2025-03-20 253160
TEVA-PAROXETINE 30MG TABLET Discontinued 2019-12-09 2019-12-09 100540
TEVA-PAROXETINE 20MG TABLET Discontinued 2019-12-09 2019-12-09 100547
TEVA-PAROXETINE 10MG TABLET Discontinued 2020-02-21 2020-02-21 106898
TEVA-PAROXETINE 30MG TABLET Discontinued 2020-02-21 2020-02-21 106901
TEVA-PIOGLITAZONE 45MG TABLET Discontinued 2018-10-19 2018-10-19 65033

Showing 221 to 240 of 299